Yuvraj

Onconova Presents Positive Clinical Trial Results for Radiation Injury Protector Ex-RAD

Onconova Therapeutics, Inc. today announced positive human safety, tolerability, and pharmacokinetic data from three clinical trials of Ex-RAD(recilisib sodium, ON 01210.Na), a novel...

Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement

Sanofi and Bristol-Myers Squibb Company have restructured their successful long-term alliance following the loss of exclusivity of Plavix and Avapro/Avalide in many major...

VentiRx, Celgene to develop cancer drug

  VentiRx Pharmaceuticals has formed a world-wide collaboration with Celgene Corporation to develop VTX-2337, a highly potent and selective TLR8 agonist for cancer treatment....

BIOGEN IDEC TO REPORT THIRD QUARTER 2012 FINANCIAL RESULTS ON OCTOBER 25, 2012

Biogen Idec Inc. today announced it will report third quarter 2012 financial results on Thursday, October 25, 2012, before the financial markets open. ...

Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement

Sanofi and Bristol-Myers Squibb Company today announced they have restructured their successful long-term alliance following the loss of exclusivity of Plavix and Avapro/Avalide...

New antibiotic cures disease by disarming pathogens

A new type of antibiotic can effectively treat an antibiotic-resistant infection by disarming instead of killing the bacteria that cause it. Researchers report...

CiToxLAB Group announces a 34 per cent revenue increase for the first half of 2012

CiToxLAB Group, a leading CRO in the field of non-clinical research, announces today that the group’s consolidated first half 2012 revenues reached EUR...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read